This session is a free information seminar by WA Dementia Training Study Centre (WA DTSC). It will provide practical information in dementia care and give the opportunity for you to network with colleagues. The seminar will focus on the needs of health professionals caring for people living with dementia.

Presenter: Dr Andrew Stafford – Director, WA Dementia Training Study Centre

Antipsychotic medications have been used in the management of changed behaviour associated with dementia (also referred to as behavioural and psychological symptoms of dementia, BPSD) for many years. This is despite their limited effectiveness and increasing evidence of adverse effects, such movement disorders, excessive sedation and an increased risk of stroke.

Risperidone is the only antipsychotic currently licensed for use in the management of changed behaviour in Australia, and it is the most commonly used antipsychotic for this purpose. However, in 2015 new restrictions upon the use of risperidone for symptoms associated with dementia were introduced because of concerns about these adverse effects.

This presentation will outline the role of medications in managing changed behaviour in people living with dementia, with a focus on the tightened restrictions upon the use of risperidone. It is aimed at health professionals working within acute and residential aged care settings.

Anyone interested in furthering their dementia knowledge, keeping up-to-date with recent research and networking with colleagues are welcome to attend.

Register online here

If you require assistance, please contact Denise Dallimore WA Dementia Training Study Centre on 9266 1830.  The seminar flyer is available to download here.